Want to see HK:0874 full AI Analyst Report?
Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Income Statement
Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement
Last quarter (Q3 2026), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was $19.98B, an increase of 1.10% from the same quarter last year. In Q3, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was $395.57M. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 77.66B | $ 74.99B | $ 75.52B | $ 70.79B | $ 69.01B | |
| $ 12.52B | $ 12.52B | $ 14.19B | $ 13.28B | $ 13.23B | |
| $ 8.89B | $ 8.92B | $ 9.07B | $ 8.73B | $ 8.85B | |
| Depreciation and Amortization | $ 931.11M | $ 875.24M | $ 929.44M | $ 743.83M | $ 676.99M |
| $ 3.95B | $ 4.90B | $ 6.49B | $ 6.22B | $ 5.82B | |
| $ 3.63B | $ 3.60B | $ 5.12B | $ 5.07B | $ 4.79B | |
| $ 61.13M | $ 11.19M | $ -10.40M | $ -31.16M | $ -62.97M | |
| $ 3.69B | $ 3.61B | $ 5.11B | $ 5.04B | $ 4.72B | |
| $ 2.98B | $ 2.84B | $ 4.06B | $ 3.97B | $ 3.72B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.83 | $ 1.74 | $ 2.49 | $ 2.44 | $ 2.29 |
| Diluted EPS | $ 1.83 | $ 1.74 | $ 2.49 | $ 2.44 | $ 2.29 |
| Weighted Average Shares Outstanding | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B |
| Weighted Average Shares Outstanding (Diluted) | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B |
Currency in CNY